NewEdge Advisors’s ENDRA Life Sciences NDRA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-20
| Closed | -$113 | – | 3979 |
|
|
2024
Q3 | $113 | Buy |
20
+3
| +18% | +$17 | ﹤0.01% | 3714 |
|
|
2024
Q2 | $2.91K | Sell |
17
-1
| -6% | -$171 | ﹤0.01% | 3256 |
|
|
2024
Q1 | $18K | Hold |
18
| – | – | ﹤0.01% | 2665 |
|
|
2023
Q4 | $66.3K | Hold |
18
| – | – | ﹤0.01% | 2114 |
|
|
2023
Q3 | $35.6K | Hold |
18
| – | – | ﹤0.01% | 2198 |
|
|
2023
Q2 | $45.2K | Sell |
18
-1
| -5% | -$2.51K | ﹤0.01% | 2113 |
|
|
2023
Q1 | $74.6K | Hold |
19
| – | – | ﹤0.01% | 1848 |
|
|
2022
Q4 | $134 | Hold |
19
| – | – | ﹤0.01% | 3341 |
|
|
2022
Q3 | $201K | Hold |
19
| – | – | ﹤0.01% | 1359 |
|
|
2022
Q2 | $153K | Hold |
19
| – | – | ﹤0.01% | 1429 |
|
|
2022
Q1 | $258K | Hold |
19
| – | – | ﹤0.01% | 978 |
|
|
2021
Q4 | $462K | Sell |
19
-1
| -5% | -$24.3K | 0.01% | 1116 |
|
|
2021
Q3 | $1.22M | Hold |
20
| – | – | 0.03% | 456 |
|
|
2021
Q2 | $1.54M | Buy |
+20
| New | +$1.54M | 0.04% | 371 |
|